Companies unite to bolster diagnostics for cancer and liver disease
Two companies set on making improvements for those with lung cancer, non-alcoholic fatty liver disease…
Two companies set on making improvements for those with lung cancer, non-alcoholic fatty liver disease…
Low-cost genetic sequencing is becoming increasingly accessible and profitable for companies, but data protection and…
Earlier this week, the tech giant IBM sold off chunks of its once-promising artificial intelligence…
As big pharma companies flock to drug discovery collaborations with artificial intelligence (AI) firms, the…
Novel computational techniques are revolutionizing the way we discover new drugs. Robert Marino, CEO and…
Phytoform, a London- and Boston-based startup, has received a €5M ($5.7M) investment to develop gene-edited…
Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts…
Artificial intelligence (AI) has become a part of everyday modern life and continues to generate…
In recent years, artificial intelligence has been hailed as the next big thing in drug…
Researchers looking to cure cancer are constantly searching for disease models that closely resemble human…
Until this year, there were no effective treatments for chronic kidney disease. However, the recent…
With the global Covid-19 outbreak in early 2020, pharma companies and biotechs have increasingly turned…